ATE295182T1 - Zusammensetzungen zur immunverstärkung von impfstoffen - Google Patents
Zusammensetzungen zur immunverstärkung von impfstoffenInfo
- Publication number
- ATE295182T1 ATE295182T1 AT98907815T AT98907815T ATE295182T1 AT E295182 T1 ATE295182 T1 AT E295182T1 AT 98907815 T AT98907815 T AT 98907815T AT 98907815 T AT98907815 T AT 98907815T AT E295182 T1 ATE295182 T1 AT E295182T1
- Authority
- AT
- Austria
- Prior art keywords
- immuno
- compositions
- boosting vaccines
- vaccines
- boosting
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1997027A CU22629A1 (es) | 1997-03-06 | 1997-03-06 | Formulaciones inmunopotenciadoras para uso vacunal |
| PCT/CU1998/000003 WO1998039032A1 (es) | 1997-03-06 | 1998-03-05 | Formulaciones inmunopotenciadoras para uso vacunal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE295182T1 true ATE295182T1 (de) | 2005-05-15 |
Family
ID=5459228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98907815T ATE295182T1 (de) | 1997-03-06 | 1998-03-05 | Zusammensetzungen zur immunverstärkung von impfstoffen |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6355414B1 (de) |
| EP (1) | EP0971737B1 (de) |
| CN (1) | CN1161154C (de) |
| AR (1) | AR009866A1 (de) |
| AT (1) | ATE295182T1 (de) |
| AU (1) | AU6607798A (de) |
| BR (1) | BR9808832A (de) |
| CA (1) | CA2283344A1 (de) |
| CU (1) | CU22629A1 (de) |
| DE (1) | DE69830156T2 (de) |
| ES (1) | ES2241122T3 (de) |
| MY (1) | MY132817A (de) |
| WO (1) | WO1998039032A1 (de) |
| ZA (1) | ZA981897B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7011845B2 (en) * | 2000-05-09 | 2006-03-14 | Mcp Hahnemann University | β-glucans encapsulated in liposomes |
| CU23011A1 (es) * | 2000-11-03 | 2004-12-17 | Ct Ingenieria Genetica Biotech | Método de obtención de estructuras antigénicas quemétodo de obtención de estructuras antigénicas que potencian la reactividad cruzada específica y su potencian la reactividad cruzada específica y su uso en formulaciones uso en formulaciones |
| CU23031A1 (es) * | 2002-01-24 | 2005-02-23 | Ct Ingenieria Genetica Biotech | Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes |
| US20060105063A1 (en) * | 2004-11-18 | 2006-05-18 | Kent Hann | Synergic combination of compositions containing aloe vera isolates and their therapeutic application |
| US8048434B2 (en) | 2005-04-25 | 2011-11-01 | Cadila Pharmaceuticals, Ltd. | Vaccine adjuvants |
| AR064359A1 (es) | 2006-12-15 | 2009-04-01 | Ca Nat Research Council | Agregados de lipidos polares de arqueas para administracion a animales |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5106616A (en) * | 1988-01-14 | 1992-04-21 | Carrington Laboratories, Inc. | Administration of acemannan |
| US5308838A (en) * | 1982-05-07 | 1994-05-03 | Carrington Laboratories, Inc. | Uses of aloe products |
| EP0418626B1 (de) * | 1989-09-08 | 1993-12-29 | Takeda Chemical Industries, Ltd. | Fusionsproteine und Herstellung davon |
| ZA93216B (en) * | 1992-01-17 | 1993-08-18 | Solvay Animal Health Inc | Vaccine containing acemannan as an adjuvant. |
| DK0642355T3 (da) * | 1992-05-23 | 1998-11-30 | Smithkline Beecham Biolog | Kombinerede vacciner, der omfatter hepatitis B-overfladeantigen og andre antigener |
| AUPM322393A0 (en) * | 1993-12-24 | 1994-01-27 | Austin Research Institute, The | Mucin carbohydrate compounds and their use in immunotherapy |
| JPH08183742A (ja) * | 1994-12-28 | 1996-07-16 | Dai Ichi Seiyaku Co Ltd | 経鼻ワクチンリポソーム |
| JP3098401B2 (ja) * | 1995-07-12 | 2000-10-16 | 株式会社エルティーティー研究所 | 経鼻投与用製剤 |
-
1997
- 1997-03-06 CU CU1997027A patent/CU22629A1/es unknown
-
1998
- 1998-03-05 BR BR9808832-7A patent/BR9808832A/pt not_active Application Discontinuation
- 1998-03-05 US US09/380,790 patent/US6355414B1/en not_active Expired - Fee Related
- 1998-03-05 AU AU66077/98A patent/AU6607798A/en not_active Abandoned
- 1998-03-05 AT AT98907815T patent/ATE295182T1/de not_active IP Right Cessation
- 1998-03-05 ZA ZA981897A patent/ZA981897B/xx unknown
- 1998-03-05 CN CNB988041456A patent/CN1161154C/zh not_active Expired - Fee Related
- 1998-03-05 ES ES98907815T patent/ES2241122T3/es not_active Expired - Lifetime
- 1998-03-05 MY MYPI98000960A patent/MY132817A/en unknown
- 1998-03-05 EP EP98907815A patent/EP0971737B1/de not_active Expired - Lifetime
- 1998-03-05 CA CA002283344A patent/CA2283344A1/en not_active Abandoned
- 1998-03-05 WO PCT/CU1998/000003 patent/WO1998039032A1/es active IP Right Grant
- 1998-03-05 DE DE69830156T patent/DE69830156T2/de not_active Expired - Fee Related
- 1998-03-06 AR ARP980101012A patent/AR009866A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA981897B (en) | 1998-09-07 |
| DE69830156D1 (de) | 2005-06-16 |
| US6355414B1 (en) | 2002-03-12 |
| AU6607798A (en) | 1998-09-22 |
| CN1252002A (zh) | 2000-05-03 |
| HK1026626A1 (en) | 2000-12-22 |
| MY132817A (en) | 2007-10-31 |
| DE69830156T2 (de) | 2006-01-26 |
| WO1998039032A1 (es) | 1998-09-11 |
| EP0971737A1 (de) | 2000-01-19 |
| CU22629A1 (es) | 2000-12-22 |
| BR9808832A (pt) | 2000-07-04 |
| ES2241122T3 (es) | 2005-10-16 |
| EP0971737B1 (de) | 2005-05-11 |
| CA2283344A1 (en) | 1998-09-11 |
| AR009866A1 (es) | 2000-05-03 |
| CN1161154C (zh) | 2004-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20004758D0 (no) | Vaksinesammensetning | |
| NO20003303D0 (no) | Vaksine | |
| ID22931A (id) | Komposisi-komposisi herbisidal | |
| DE69832516D1 (de) | Isoflavon-enthaltende zusammensetzungen | |
| DK1298194T3 (da) | Staniolholdige sammensætninger | |
| ID28965A (id) | Azabisikloalkana sebagai modulator ccr5 | |
| IS5430A (is) | Ný samsetning | |
| BR9711853A (pt) | Vacinas | |
| DE69933200D1 (de) | Kombinierte impfstoffzusammensetzungen | |
| DE69832185D1 (de) | Dichroischer polarisator | |
| ID22891A (id) | Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan | |
| ID25508A (id) | Komposisi dematologis | |
| NO20006191D0 (no) | Vaksine | |
| ID17860A (id) | Komposisi vaksin | |
| ID21009A (id) | Komposisi untuk supositori | |
| DE69720257D1 (de) | Träger zur befestigung von gegenständen | |
| NO984662L (no) | Vann-i-olje-emulsjonsgj°dningsstoff-sammensetninger | |
| DK0897667T3 (da) | Brödforbedrende sammensætning | |
| ID23250A (id) | Komposisi paroksetin | |
| ID21906A (id) | Komposisi adesif | |
| DE69822559D1 (de) | Siliconzusammensetzung | |
| ID29294A (id) | Komposisi farmasi | |
| DE69826706D1 (de) | Wäscheweichmittelzusammensetzungen | |
| DE69804218D1 (de) | Zementzusammensetzung | |
| NO20005599D0 (no) | Vaksine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0971737 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |